Lyell Immunopharma, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2019 | 132.6M |
| FY2020 | 132.6M |
| FY2021 | 135.9M |
| FY2022 | 247.1M |
| FY2023 | 12.5M |
| FY2024 | 13.1M |
| FY2025 | 17.1M |
| FY2026 | 23.3M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2019 | 132.6M |
| FY2020 | 132.6M |
| FY2021 | 135.9M |
| FY2022 | 247.1M |
| FY2023 | 12.5M |
| FY2024 | 13.1M |
| FY2025 | 17.1M |
| FY2026 | 23.3M |